Official UK procurement notice
Provision of reagents for GridION platforms to support COG-UK
Authority: Public Health England
What is being bought
Published requirement descriptionPublic Health England (PHE) has awarded a contract to New England Biolabs UK Ltd for the provision of reagents to be used on GridION platforms urgently needed to support the COVID-19 Genomics UK (COG-UK) consortium work.
PHE discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health within the scope of the Civil Contingencies Act 2004 (CCA 2004). This urgent requirement is in response to the COVID -19 outbreak.
CPV: Chemical reagents
The lotProcurement structure
single lot · no lot value publishedLot #1This single tender action request is for the purpose of procuring reagents to be used…Awarded
This single tender action request is for the purpose of procuring reagents to be used on GridION platforms needed to support the COVID-19 Genomics UK (COG-UK) consortium work.
Procedure terms & legal framework
From the official record- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 7 Apr 2021, 22:56 BST
- Last source update
- 7 Apr 2021, 22:56 BST
- FTS notice number
2021/S 000-007163- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02a36cFind a Tender
- Why no open competition
Extreme urgency brought about by events unforeseeable for the contracting authority/entity and in accordance with the strict conditions stated in the directive
- Published justification
The UK Government must protect the health and wellbeing of UK citizens. The COVID-19 outbreak is a Public Health Emergency of International Concern (PHEIC) as declared by the World Health Organisation on 30 January 2020. The WHO Director General characterised COVID-19 as a pandemic on 11 March 2020.
PHE discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health and Social Care within the scope of the Civil Contingencies Act 2004 (CCA 2004). This urgent requirement is in response to the COVID -19 outbreak.
The negotiated procedure without a prior publication has been used due to extreme urgency on the grounds of regulation 32(2)(c). This requirement is provided at short notice to support reduced testing turnaround times which are critical in the current outbreak and increased coronavirus testing capacity using an approved assay.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| New England Biolabs UK LtdSME | £264,000 † | — | Awarded |
Contracts
Contract 007163-2021-1 · New England Biolabs UK LtdSME
- Signed
- 15 Jan 2021
- Value
- £264,000
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- New England Biolabs UK LtdAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.